In what the Cherokee Nation described as “an attack on the very sovereignty of our nation,” several pharmaceutical distributors and retail pharmacies have asked a federal judge to prevent a lawsuit against them over the opioid addiction epidemic from proceeding in tribal court.
The companies’ complaint, filed Thursday in the U.S. District Court for the Northern District of Oklahoma, alleges that the Cherokee Nation district court does not have jurisdiction to civilly enforce the federal Controlled Substances Act, nor does the alleged behavior “threaten either tribal governance or internal relations among tribe members.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
